Recombinant fowlpox viruses coexpressing chicken type I IFN and newcastle disease virus HN and F genes: Influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses

Vaccine

Volumn 16, Issue 16, 1998, Pages 1496-1503

  Karaca, Kemal ^a   Sharma, Jagdev M ^a   Winslow, Barbara J ^b   Junker, David E ^b   Reddy, Sudhir ^a   Cochran, Mark ^b   McMillen, Janis ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Syntro Research Laboratories   (United States)

^c Syntro Vet Inc   (United States)

Author keywords

Chicken; Hemagglutinin neuraminidase of Newcastle disease virus; In ovo; Recombinant fowlpox virus; Type I interferon

Indexed keywords

ANTIBODY; HN PROTEIN; HYBRID PROTEIN; INTERFERON; VIRUS VACCINE;

ARTICLE; CHICKEN; DRUG EFFICACY; EMBRYO; FOWLPOX VIRUS; GENE; HUMORAL IMMUNITY; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SEROLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; VACCINATION; VIRUS RECOMBINANT; WEIGHT GAIN;

ANIMALS; ANTIBODY FORMATION; BODY WEIGHT; CHICK EMBRYO; CHICKENS; FOWLPOX; FOWLPOX VIRUS; GENE EXPRESSION; HN PROTEIN; INTERFERON TYPE I; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS;

EID: 0032192681     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00295-8     Document Type: Article

References (54)

1. 1 Glisson, J.R. and Kleven, S.H. Poultry vaccines. In: Vaccines for Veterinary Applications (Ed. Peter, A.R.). Butterworth-Heinemann, Oxford, 1993, pp. 165-198.
2. 2 Mazariegos, L.A., Lukert, P.D. and Brown, J. Pathogenicity and immunosuppressive properties of infectious bursal disease "intermediate" strains. Avian Dis. 1990, 34, 203-208.
3. 3 Beard, C.W. and Hanson, R.P. Newcastle disease. In: Diseases of Poultry, 8th edition (Eds Hofstad, M.S., Barnes, H.J., Calnek, B.W., Reid, W.M. and Yoder, H.W.). Iowa State University Press, Ames, 1984, pp. 452-470.
4. 4 Springer, W.T. and Truman, R.W. Effect of subcutaneous pox vaccination of young chickens on immune responses and weight gains. Poult. Sci. 1981, 60, 1213-1220.
5. 5 Tripathy, D.N. Pox. In: Diseases of Poultry, 9th edition (Eds Calnek, B.W., Barnes, J.H., Beard, C.W., Reid, W.M. and Yoder, H. W. Jr). Iowa State University Press, Ames, 1991, pp. 583-596.
6. 6 Taylor, J., Weinberg, W., Kawaoka, Y., Webster, R. and Paoletti, E. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 1998, 6, 504-508.
7. 7 Boyle, D.B. and Coupar, B.E.H. Construction of recombinant fowlpox viruses as vectors for poultry vaccine. Virus Res. 1988, 10, 343-356.
8. 8 Edbauer, C., Weinberg, R. and Taylor, J. et al. Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene. Virol. 1990, 179, 901-904.
9. 9 Boursnell, M.E.G., Green, P.F. and Campbell, J.I.A. et al. Insertion of fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. J. Gen. Virol. 1990, 71, 621-628.
10. 10 Taylor, J., Edbauer, C. and Rey-senelonge, A. et al. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 1990, 64, 1441-1450.
11. 11 Tripathy, D.N. and Schnitzlein, W.M. Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus. Avian Dis. 1991, 35, 186-191.
12. 12 Beard, C.W., Schnitzlein, W.M. and Tripathy, D.N. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis. 1991, 35, 356-359.
13. 13 Bayliss, C.D., Peters, R.W. and Cook, J.K.A. et al. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Virol. 1991, 120, 193-205.
14. 14 Letellier, C., Burny, A. and Meulemanns, G. Construction of a pidgeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. Arch. Virol. 1991, 118, 43-56.
15. 15 Webster, G.R., Kawoka, Y., Taylor, J., Weinberg, R. and Paoletti, E. Efficacy of nucleoprotein and hemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 1991, 9, 303-308.
16. 16 Iritani, Y., Aoyama, S. and Takigami, S. et al. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV. Avian Dis. 1991, 35, 659-661.
17. 17 Beard, C.W., Schnitzlein, W.M. and Tripathy, D.N. Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza. Avian Dis. 1992, 36, 1052-1055.
18. 18 Nazerian, K., Lee, L.F., Yanagida, N. and Ogawa, R. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 1992, 66, 1409-1413.
19. 19 Boursnell, M.E.G. Avipoxvirus vectors. In: Recombinant Poxviruses (Eds Binns, M.M. and Smith, G.L.). CRC Press, Boca Raton, 1992, pp. 269-285.
20. 20 Boyle, D.B. and Heine, H.G. Recombinant fowlpox virus vaccines for poultry. Immunol. Cell Biol. 1993, 71, 391-397.
21. 21 Heine, H. and Boyle, D.B. Infectious bursal disease virus structural protein VP2 expressed by fowlpox virus recombinant confers protection against disease in chickens. Arch. Virol. 1993, 131, 277-292.
22. 22 Calvert, J.G., Nazerian, K., Witter, R.L. and Yanagida, N. Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens. J. Virol. 1993, 67, 3069-3076.
23. 23 Boyle, D.B. and Heine, H.G. Influence of dose and route of inoculation on responses of chickens to recombinant fowlpox virus vaccines. Vet. Microbiol. 1994, 41, 173-181.
24. 24 Heine, H.G., Hyatt, A.D. and Boyle, D.B. Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity. Virus Res. 1994, 32, 313-328.
25. 25 Mc Millen, J. K., Cochran, M. D., Junker, D. E., Reddy, D. N. and Valencia, D. M. The safe and effective use of fowlpox virus as a vector for poultry vaccine. Dev. Biol. Std. 1994, 82, 137-145.
26. 26 Yoshida, S., Lee, L.F., Yanagida, N. and Nazerian, K. The glycoprotein B genes of Marek's disease virus serotype 2 and 3: identification and expression by recombinant fowlpox viruses. Virol. 1994, 200, 484-493.
27. 27 Nazerian, K., Witter, R.L., Lee, L.F. and Yanagida, N. Protection and synergism by recombinant fowlpox vaccine expressing genes from Marek's disease virus. Avian Dis. 1996, 40, 368-376.
28. 28 Sondermeijer, P.J.A., Claessens, J. and Jenniskens, P. et al. Avian herpesvirus as alive vector for the expression of heterologous antigens. Vaccine 1993, 11, 349-358.
29. 29 Reddy, S.K., Sharma, J.M. and Ahmad, J. et al. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 1996, 14, 469-477.
30. 30 Nussler, A.K. and Thompson, A.W. Immunomodulatory agents in the laboratory and clinic. Parasitology 1992, 105, S5-S23.
31. 31 Arai, K., Lee, F., Miyajima, A., Shoichiro, M., Arai, N. and Yokota, T. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 1990, 59, 783-836.
32. 32 Balkwill, F. Cytokines in health and disease. Immunol. Today 1993, 14, 149-150.
33. 33 Heath, A.W. and Playfair, J.H.L. Cytokines as immunological adjuvants. Vaccine 1992, 10, 427-434.
34. 34 Reddy, D.N., Reddy, P.G., Xue, W., Minocha, H.C., Daley, M.J. and Blecha, F. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2. Vet. Immun. Immunopathol. 1993, 37, 25-38.
35. 35 Gao, Y., Daley, M. and Splitter, G.A. BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response. Vaccine 1995, 13, 871-877.
36. 36 Blecha, F., Reddy, D.N. and Chitkomckown, C.G. et al. Influence of recombinant bovine interleukin-1 beta and interleukin-2 in pigs vaccinated and challenged with Streptococcus suis. Vet. Immun. Immunopathol. 1995, 44, 329-346.
37. 37 Anderson, G., Urbano, O., Fedorka-Cray, P., Nunberg, J. and Doyle, M. (1987) Interleukin 2 and protective immunity in Haemophilus pleuropneumonia. Preliminary studies. In: Vaccines '87. Cold Spring Harbor Press, Cold Spring Harbor, pp. 22-25.
38. 38 Nunberg, J., Doyle, M.V., York, S.M. and York, C.J. Interleukin 2 acts as an adjuvant to enhance the potency of inactivated rabies virus vaccine. Proc. Natl Acad. Sci. 1989, 86, 4240-4243.
39. 39 Weinberg, A. and Merigan, T.C. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunisation of guinea pigs with herpes simplex virus subunit vaccines. J. Immunol. 1988, 140, 294-298.
40. 40 McCullough, K.C., Pullen, L. and Parkinson, D. The immune response against foot-and-mouth disease virus:influence of the T lymphocyte growth factors IL-1 and IL-2 on the murine humoral response in vivo. Immunol. Lett. 1992, 31, 41-46.
41. 41 Ramsay, J.A., Husband, J.A. and Ramshaw, I.A. et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994, 264, 561-563.
42. 42 Leong, K.H., Ramsay, A.J., Boyle, D.B. and Ramshaw, I.A. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J. Virol. 1994, 68, 8125-8130.
43. 43 Schat, K. A. T cell immunity: mechanism and soluble mediators. In: Avian Cellular Immunology (Ed. Sharma, J. M.). CRC Press, Boca Raton, 1991, pp. 35-50.
44. 44 Sugano, S., Stoeckle, M. and Hanafusa, H. Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein. Cell 1987, 49, 321-328.
45. 45 Leutz, A., Damm, K. and Sterneck, E. et al. Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. EMBO J. 1989, 8, 175-181.
46. 46 Burt, D.W. and Paton, I.R. Molecular cloning and primary structure of chicken transforming growth factor-beta 2 gene. DNA Cell. Biol. 1991, 10, 723-734.
47. 47 Sekellick, M.J., Ferrandino, A.F., Hopkins, D.A. and Marcus, P.I. Chicken interferon gene: cloning expression and analysis. J. Interferon Res. 1994, 14, 71-79.
48. 48 Digby, M.R. and Lowenthal, J.W. Cloning and expression of chicken interferon-gamma gene. J. Interferon and Cytokine Res. 1995, 15, 939-945.
49. 49 Suresh, M., Karaca, K., Foster, D. and Sharma, J. Molecular and biological characterization of turkey interferon. J. Virol. 1995, 69, 8159-8163.
50. 50 Sharma, J.M. and Witter, R.L. Embryo vaccination against Marek's disease with serotypes 1, 2, and 3 vaccines administered singly or in combination. Avian Dis. 1983, 27, 453-463.
51. 51 Belardelli, F. Role of interferons and other cytokines in regulation of immune response. APMIS 1995, 103, 161-179.
52. 52 Tough, D.F., Borrow, P. and Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996, 272, 1947-1950.
53. 53 York, J.J., Storm, A.D., Connick, T.E., McWaters, P.G., Boyle, D.B. and Lowenthal, J.W. In vivo effects of chicken myelomonocytic growth factor: delivery via a viral vector. J. Immunol. 1996, 156, 2991-2997.
54. 54 Spriggs, M.K. Poxvirus-encoded soluble cytokine receptors. Virus Res. 1994, 33, 1-10.